PARP1/BRD4-IN-1 is a potent and highly selective inhibitor of PARP1 and BRD4 (IC50 = 49 nM and 202 nM, respectively), used to synergistically suppress the malignant growth of pancreatic cancer cells by inhibiting the expression and activity of PARP1 and BRD4.